Core Viewpoint - Lu Kang Pharmaceutical (600789) has received a government subsidy of 14,360,000.00 yuan, which is expected to positively impact the company's profits for the fiscal year 2025 [1] Financial Performance - As of December 9, 2025, Lu Kang Pharmaceutical's stock closed at 9.52 yuan, down 1.45% from the previous trading day [1] - The stock opened at 9.67 yuan, reached a high of 9.74 yuan, and a low of 9.51 yuan, with a trading volume of 2.56 billion yuan and a turnover rate of 2.97% [1] - The latest total market capitalization of the company is 85.55 billion yuan [1] Government Subsidy - The government subsidy received by Lu Kang Pharmaceutical accounts for 3.52% of the company's audited net profit for the fiscal year 2024 [1] - The subsidy is categorized as an asset-related government grant, which is anticipated to have a positive effect on the company's profits for the fiscal year 2025 [1] - The final accounting treatment and impact on annual profit and loss will be confirmed by the auditing institution [1]
鲁抗医药(600789)披露获得政府补助,12月09日股价下跌1.45%